Tag: THERANEXUS
THERANEXUS: Monthly information relating to the total number of voting rights and shares making up the share capital – 04/06/2022 at 6:00 p.m.
Lyon, April 6, 2022 – Theranexus, an innovative biopharmaceutical company in the treatment of neurological diseases and a pioneer in the development of drug candidates acting on the interaction between…
THERANEXUS: MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPOSING THE SHARE CAPITAL – 02/10/2022 at 6:40 p.m.
Lyon, February 10, 2022 – Theranexus, an innovative biopharmaceutical company in the treatment of neurological diseases and a pioneer in the development of drug candidates acting on the interaction between…
THERANEXUS: THERANEXUS AND THE BBDF FOUNDATION INITIATE RECRUITMENT FOR THE PHASE I/II STUDY IN BATTEN’S DISEASE – 02/03/2022 at 18:00
Lyon, France – Austin, Texas, United States – February 3, 2022 – Theranexus, an innovative biopharmaceutical company in the treatment of neurological diseases and a pioneer in the development of…
Theranexus: share price falls after dilutive financing – 01/14/2022 at 12:03
(CercleFinance.com) – Theranexus shares fell by more than 17% on Friday on the Paris Stock Exchange the day after the implementation of a new line of equity financing, with a…
THERANEXUS: THERANEXUS PUBLISHES ITS 2022 FINANCIAL AGENDA – 12/20/2021 at 6:00 p.m.
Lyon, December 20, 2021 – Theranexus, an innovative biopharmaceutical company in the treatment of neurological diseases and a pioneer in the development of drug candidates acting on the interaction between…